Doripenem Injection 250 mg – High-Quality Sterile Antibiotic for Canberra, Australia
Manufactured with Precision for Modern Healthcare
Ernest Oncology presents Doripenem Injection 250 mg, a sterile injectable carbapenem antibiotic manufactured in India using advanced pharmaceutical technology. Produced within WHO-GMP certified facilities, every vial is carefully processed under validated aseptic conditions to ensure exceptional purity, sterility, product stability, and consistent pharmaceutical performance.
This sterile formulation is intended for intravenous (IV) administration by qualified healthcare professionals.
Canberra Pharmaceutical Market Information
Canberra's healthcare system is supported by advanced hospitals, specialist medical centres, research institutions, and modern clinical facilities that rely on high-quality pharmaceutical products. Sterile injectable antibiotics continue to play an important role in hospital-based treatment, where product quality, manufacturing reliability, and pharmaceutical consistency remain essential.
India has become one of the world's leading pharmaceutical manufacturing nations, supplying high-quality medicines through internationally recognized production standards and continuous scientific innovation.
Why Indian Pharmaceutical Manufacturing is Globally Preferred
Indian pharmaceutical manufacturers have earned worldwide recognition by consistently delivering medicines that meet international expectations for quality and safety.
Manufacturing Excellence
- WHO-GMP certified manufacturing facilities
- Advanced sterile production technology
- International pharmaceutical quality standards
- High-purity pharmaceutical ingredients
- Reliable batch consistency
- Comprehensive quality assurance systems
- Export-standard packaging
- Modern microbiological testing
- Continuous manufacturing innovation
- Globally trusted pharmaceutical expertise
Product Overview
| Product Information | Details |
|---|---|
| Product Name | Doripenem Injection |
| Strength | 250 mg |
| Active Ingredient | Doripenem |
| Dosage Form | Sterile Powder for Injection |
| Administration Route | Intravenous (IV) |
| Drug Category | Carbapenem Antibiotic |
| Packaging | Sterile Glass Vial |
| Manufactured In | India |
Key Features
- Sterile Doripenem formulation
- Carbapenem antibiotic class
- Intravenous injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable formulation
- Batch-tested quality
- Sterility validated
- Export-quality packaging
- Manufactured using advanced aseptic technology
Recommended Dosage
Dosage should always be determined by a qualified healthcare professional.
Treatment is based on:
- Nature of the bacterial infection
- Severity of illness
- Age of the patient
- Body weight
- Kidney function
- Individual clinical assessment
Administration should always be performed by trained medical personnel.
Possible Side Effects
Some patients may experience temporary side effects while receiving treatment.
Possible reactions include:
- Headache
- Nausea
- Vomiting
- Diarrhea
- Injection site discomfort
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary liver enzyme elevation
Consult your healthcare provider if symptoms persist or become severe.
Safety Information
- Prescription-only medicine.
- Intended for intravenous administration by healthcare professionals.
- Inform your doctor about previous allergies to antibiotics.
- Complete the prescribed course of treatment.
- Do not use expired medicine.
- Keep out of the reach of children.
- Follow medical instructions carefully.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in the original packaging
- Do not freeze
- Use before the expiry date
Product Description
Doripenem Injection 250 mg contains Doripenem, a carbapenem antibiotic supplied as a sterile powder for intravenous administration. Manufactured using modern pharmaceutical technology, the formulation is designed to maintain sterility, product integrity, and pharmaceutical consistency throughout its manufacturing process.
Each vial undergoes comprehensive quality evaluation before release to ensure dependable pharmaceutical standards.
Mechanism of Action
Doripenem works by preventing bacteria from forming protective cell walls.
It binds to penicillin-binding proteins within susceptible bacteria, interrupting cell wall synthesis and leading to bacterial destruction. This mechanism helps manage susceptible bacterial infections when prescribed by healthcare professionals.
